Pharma Commercial Forecasting Expert: Launch Curves

What you'll do

A biotech and pharma research team is building expert human evaluation of how AI analyses commercial drugs and development programs, and this listing is the commercial forecasting seat. You create and critique rubrics for that analysis, and apply your forecasting judgment across the pilot's set of drug launches:

• Build or critique a launch curve: uptake, peak share and trajectory
• Judge whether a forecast's assumptions are defensible: the analogs chosen, the ramp, the peak, and the loss-of-exclusivity cliff
• Turn that judgment into rubric criteria that separate a credible forecast from a plausible-looking one

Anyone who has sat through a forecast review knows the failure mode being tested for: a clean curve built on a weak analog, or a peak share nobody could defend in front of brand leadership. Writing that down as checkable criteria is the core of the work.

This is one of four sister pilots from the same team, each covering a different lens on the drugs: forecasting (this one), clinical trial interpretation, payer and market access, and epidemiology.

Who fits

• A US-based pharma commercial or forecasting professional; the ad explicitly says people from pharma sales teams can apply too
• Familiarity with biotech and pharma development programs
• Experience building or critiquing drug launch or uptake models
• 5+ years in pharma commercial forecasting, analytics or strategy

This is the only one of the four pilots with a formal United States location requirement on the ad.

What it pays

$130–210 per hour, an $80 spread that ties with the clinician pilot for the widest of the four, and the lowest floor. At 10–20 hours that is roughly $1,300–4,200 for the pilot. Payments are weekly on Stripe or Wise, as an independent contractor. The ad does not say what places you in the band.

Commitment

About 10–20 hours in total, over one to two weeks. It is a pilot: the ad offers recurring engagement for strong contributors as the work scales, but nothing beyond the pilot is guaranteed.

Worth knowing

Good:

• High hourly rate for commercial rather than clinical expertise
• Short, defined pilot, easy to fit around a day job
• Sales backgrounds explicitly welcome, which is unusual for forecasting work
• A path to recurring work if the pilot goes well

Less good:

• 10–20 hours total, so the income is modest unless the work continues
• An $80 spread in the band with no published basis for placement
• US-based only; H-1B and STEM OPT candidates cannot be supported
• You cannot bring in your employer's forecasts or data, which Mercor rules out
• The research team is not named

About this listing

Posted by Mercor as a part-time remote pilot restricted to the United States, confirmed open on 24 September 2026. The pay band, pilot duration and requirements are the ad's own. See Mercor.